Results 271 to 280 of about 104,967 (312)
Some of the next articles are maybe not open access.
Pulmonary function studies after smoke inhalation
The American Journal of Surgery, 1976Pulmonary function studies were performed within 72 hours of injury in seven patients with smoke inhalation injury diagnosed by positive 133Xe scintiphotographs and in eight patients with burns of similar size but with negative 133Xenon scans. The former patients showed decreased peak flow, decreased flow at 25, 50, and 75 per cent of vital capacity ...
P A, Petroff +3 more
openaire +2 more sources
Pulmonary manifestations of inhaled street drugs
Heart & Lung, 1998S ince 1611, when the Jamestown colonists first harvested tobacco, America has witnessed almost 4 centuries of inhalation drug abuse. The first general misuse of tobacco and drugs (opiates) occurred during the 16th century, when these substances were used as a substitute for legal currency.1 Drug scares have come and gone in cycles.
R, Cruz +5 more
openaire +2 more sources
Inhaled Iloprost in Pulmonary Arterial Hypertension
Annals of Pharmacotherapy, 2005OBJECTIVE To review the pharmacology, pharmacodynamics, and clinical trials evaluating inhaled iloprost in pulmonary arterial hypertension (PAH). DATA SOURCES A MEDLINE search (1996–February 2005) was performed using the key words pulmonary hypertension, iloprost, and epoprostenol.
Stacey E, Baker, Rebecca Haynes, Hockman
openaire +2 more sources
Pulmonary Drug Delivery: Medicines for Inhalation
2009Mankind has inhaled substances for medical and other reasons for thousands of years, notably resulting in the cultural manifestations of tobacco and opium smoking. Over the course of time concepts of pulmonary application, including inhalation devices and drug formulations, have been and still are being continuously developed.
Andreas, Henning +4 more
openaire +2 more sources
Age, Smoking Inhalation, and Pulmonary Function
Archives of Environmental Health: An International Journal, 1975This study examined the relative effects of age and smoking on pulmonary function. Smoking was measured by six smoking variables, taken singly and as a composite. Subjects were 1,516 male participants in the Normative Aging Study. A stepwise multiple regression with vital capacity (VC) and forced expiratory volume at one second (FEV1.0) as the criteria
R, Bossé +3 more
openaire +2 more sources
Pulmonary effects of inhaled ultrafine particles
International Archives of Occupational and Environmental Health, 2000Recent epidemiological studies have shown an association between increased particulate urban air pollution and adverse health effects on susceptible parts of the population, in particular the elderly with pre-existing respiratory and cardiovascular diseases. Urban particles consist of three modes: ultrafine particles, accumulation mode particles (which
openaire +2 more sources
Pulmonary effects of inhaled cannabis smoke
The American Journal of Drug and Alcohol Abuse, 2019Background: The smoke generated from cannabis delivers biologically active cannabinoids and a number of combustion-derived toxins, both of which raise questions regarding the impact of cannabis smoking on lung function, airway inflammation and smoking-related lung disease.Objectives: Review the potential effects of cannabis smoking on respiratory ...
Donald P. Tashkin, Michael D. Roth
openaire +2 more sources
Inhaled Nitric Oxide and Pulmonary Vasoreactivity
Journal of Clinical Monitoring and Computing, 2000Inhaled nitric oxide is a ubiquitous molecule which is produced endogenously and is also found in air pollution and in cigarette smoke. After describing the chemistry of NO, we review its history from the first description in 1980 to the current clinical indications.
M, Aranda, R G, Pearl
openaire +2 more sources
Drugs, 2004
Iloprost is a stable prostacyclin analogue with a pharmacokinetic profile allowing nebulised administration in patients with primary pulmonary hypertension (PPH). Inhaled iloprost is a potent acute pulmonary vasodilator with a duration of action of about 60 minutes.
David R, Goldsmith, Antona J, Wagstaff
openaire +2 more sources
Iloprost is a stable prostacyclin analogue with a pharmacokinetic profile allowing nebulised administration in patients with primary pulmonary hypertension (PPH). Inhaled iloprost is a potent acute pulmonary vasodilator with a duration of action of about 60 minutes.
David R, Goldsmith, Antona J, Wagstaff
openaire +2 more sources
Inhalational Pulmonary Talcosis
Journal of Thoracic Imaging, 2004We describe the high-resolution CT findings in 3 patients with pulmonary talcosis acquired by the inhalation of talc. The predominant abnormalities consisted of small centrilobular and subpleural nodules and conglomerated masses containing focal areas of high attenuation consistent with talc deposition.
Edson, Marchiori +2 more
openaire +2 more sources